ERŞAHİN, M. Et Al. 2012. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. PROSTAGLANDINS & OTHER LIPID MEDIATORS , vol.99 , 131-139.

ERŞAHİN, M., ÇEVİK, Ö., AKAKIN, D., ŞENER, A., ÖZBAY, L., YEGEN, B., ... ŞENER, G.(2012). Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. PROSTAGLANDINS & OTHER LIPID MEDIATORS , vol.99, 131-139.

ERŞAHİN, MEHMET Et Al. "Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury," PROSTAGLANDINS & OTHER LIPID MEDIATORS , vol.99, 131-139, 2012

ERŞAHİN, MEHMET Et Al. "Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury." PROSTAGLANDINS & OTHER LIPID MEDIATORS , vol.99, pp.131-139, 2012

ERŞAHİN, M. Et Al. (2012) . "Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury." PROSTAGLANDINS & OTHER LIPID MEDIATORS , vol.99, pp.131-139.

@article{article, author={MEHMET ERŞAHİN Et Al. }, title={Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury}, journal={PROSTAGLANDINS & OTHER LIPID MEDIATORS}, year=2012, pages={131-139} }